Craig Eagle - Feb 8, 2024 Form 3 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
Director
Signature
/s/ Nathen Fuentes, Attorney-in-Fact for Craig Eagle
Stock symbol
TELO
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
3
Date filed
2/8/2024, 05:46 PM
Previous filing
Jan 3, 2024
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TELO Common Stock 488K Feb 8, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.